FDA Approved: ALIMTA — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for ALIMTA (pemetrexed disodium) from Eli Lilly and Company, updating its labeling with additional indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)

Snippet

SUPPL AP for ALIMTA (PEMETREXED DISODIUM)